the grants from the National Natural Science Foundation of China(No.81602050);the Foundation of the First Affiliated Hospital of Harbin Medical University(No.201713008);the China Postdoctoral Science Foundation(Nos.2018M 631947 and 2020T 130158);the Heilongjiang Postdoctoral Foundation(No.LBH-Z18125);the Heilongjiang Province General Undergraduate Colleges and Universities Young Innovative Talents Training Plan(No.UNPYSCT-2017063);the Wu Jieping Medical Foundation(No.320.6750.16018).
Intrahepatic cholangiocarcinoma(ICC)arises from cholangiocytes in the intrahepatic bile duct and is the second most common type of liver cancer.The overexpression of COUP-TFⅡ has been observed in several types of mal...
Supported by Fondo per gli Investimenti della Ricerca di Base(FIRB)(RBAP10MY35_002);by Ente Cassa di Risparmio di Firenze;by FiorGen ONLUS to Galli A
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a median overall survival time of 5 mo and the five years survival less than 5%, a rate essentially unchanged over the course of the years. A well ...